Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment.
Explore this paper's citation graph
Summary
Substantial changes included a redefinition of the midline, restrictions on age and bone marrow involvement for stage 4S, and the recommendation that meta-iodobenzylguanidine scanning be implemented for evaluating the extent of disease.
- Type
- review
- Published
- 1993-08-01
- Cited by
- 2,060
- References
- 118
- OpenAlex
- https://openalex.org/W2096398040
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:1174486
Keywords
Neuroblastoma, Medicine, Stage (stratigraphy), Enolase, Oncology
References
- High-dose rapid schedule chemotherapy for disseminated neuroblastoma.
- Localized neuroblastoma. Surgical and pathologic staging
- Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
- Systemic interleukin-2 therapy in children with progressive neuroblastoma after high dose chemotherapy and bone marrow transplantation.
- Immunohistochemical localization of neurofilaments and neuron-specific enolase in 29 cases of neuroblastoma.
- Neuroblastoma in the very young child: biological considerations.
- Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry.
- Possible differential diagnosis of neuroblastoma from rhabdomyosarcoma and Ewing's sarcoma by using a panel of monoclonal antibodies.
- Expression of the neuronal form of pp60c-src in neuroblastoma in relation to clinical stage and prognosis.
- Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas.
- Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
- Models to predict outcome from childhood neuroblastoma: the role of serum ferritin and tumor histology.
- Age-dependent prognostic significance of N-myc amplification in neuroblastoma. The Italian experience.
- Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
- Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: report of 34 cases.
- Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies.
- Effects of a single course of deferoxamine in neuroblastoma patients.
- A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study Group.
- Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas.
- Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
Cited by
- Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results. Italian Neuroblastoma Cooperative Group.
- Immunohistochemical detection of p140trkA and p75LNGFR neurotrophin receptors in neuroblastoma
- Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers.
- Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
- Natriuretic Peptide Receptors of Type A in Human Neuroblastomas
- Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.
- Severe oral mucositis after therapeutic administration of [131I]MIBG in a child with neuroblastoma.
- Malignant abdominal masses in children: quick guide to evaluation and diagnosis.
- Radiographic assessment of resectability of locoregional disease in children with high‐risk neuroblastoma during neoadjuvant chemotherapy
- Liver involvement in neuroblastoma: The memorial Sloan‐Kettering experience supports treatment reduction in young patients
- Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation.
- Arsenic trioxide and neuroblastoma cytotoxicity
- Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
- Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification.
- Aktuelle Therapiestrategien beim Neuroblastom
- Bone Marrow-Infiltrating Human Neuroblastoma Cells Express High Levels of Calprotectin and HLA-G Proteins
- Symptomatic Epidural Compression in Infants With Neuroblastoma: A Single-Center Experience With 5 Cases
- Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: High incidence of endocrine and growth problems
- RNA helicase A is a downstream mediator of KIF1Bβ tumor-suppressor function in neuroblastoma.
- (18)F-FDG-PET/CT, (123)I-MIBG and (99m)Tc-MDP whole-body scans, in detecting recurrence of an adult adrenal neuroblastoma.
Related papers
- Enzymatic determination of serum neuron-specific enolase in small cell lung cancers. Utility of the serum neuron-specific enolase/serum nonneuronal enolase ratio
- Neuron specific enolase and traumatic brain injury
- Neuron-specific enolase in relation to differentiation in human neuroblastoma.
- Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
- Neuron specific enolase: a marker for differential diagnosis of neuroblastoma and Wilms' tumor.
- Detection of the PGP9.5 and tyrosine hydroxylase mRNAs for minimal residual neuroblastoma cells in bone marrow and peripheral blood.
- A study of the TNM staging system for nasopharyngeal carcinoma (NPC)
- Imaging Staging of the Nasopharyngeal Angiofibroma( 94 Cases Report)
- Classifying clinical severity to help solve problems of stage migration in nonconcurrent comparisons of lung cancer therapy.